Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York.
Department of Diagnostic Ultrasound, Tong Ren Hospital, Capital Medical University, Beijing, People's Republic of China.
J Thorac Oncol. 2019 May;14(5):890-902. doi: 10.1016/j.jtho.2019.01.013. Epub 2019 Jan 24.
To determine long-term survival of visceral pleural invasion (VPI) and parenchymal invasion (PAI) (angiolymphatic and/or vascular) on survival of NSCLCs less than 30 mm in maximum diameter.
Kaplan-Meier survivals for NSCLCs, with and without VPI and/or PAI, were determined for a prospective cohort of screening participants stratified by pathologic tumor size (≤10 mm, 11-20 mm, and 21-30 mm) and nodule consistency. Log-rank test statistics were calculated.
The frequency of PAI versus VPI was significantly lower in patients with subsolid nodules than in those with solid nodules (4.9% versus 27.7% [p < 0.0001]), and correspondingly, Kaplan-Meier lung cancer survival was significantly higher among patients with subsolid nodules (99.1% versus 91.3% [p = 0.0009]). Multivariable Cox regression found that only tumor diameter (adjusted hazard ratio [HR] =1.07, 95% confidence interval [CI]: 1.01-1.14, p = 0.02) and PAI (adjusted HR = 3.15, 95% CI: 1.25-7.90, p = 0.01) remained significant, whereas VPI was not significant (p = 0.15). When clinical and computed tomography findings were included with the pathologic findings, Cox regression showed that the risk of dying of lung cancer increased 10-fold (HR = 10.06, 95% CI: 1.35-75.30) for NSCLCs in patients with solid nodules and more than twofold (by a factor of 2.27) in patients with moderate to severe emphysema (HR = 2.27, 95% CI: 1.01-5.11), as well as with increasing tumor diameter (HR = 1.06, 95% CI: 1.01-1.13), whereas PAI was no longer significant (p = 0.19).
Nodule consistency on computed tomography was a more significant prognostic indicator than either PAI or VPI. We propose that patients with NSCLC with VPI and a maximum tumor diameter of 30 mm or less not be upstaged to T2 without further large, multicenter studies of NSCLCs, stratified by the new T status and that classification be considered separately for patients with subsolid or solid nodules.
确定最大直径小于 30mm 的非小细胞肺癌(NSCLC)中内脏胸膜侵犯(VPI)和实质侵犯(PAI)(血管淋巴管和/或血管)对生存的长期影响。
对筛查参与者的前瞻性队列进行分析,根据病理肿瘤大小(≤10mm、11-20mm 和 21-30mm)和结节密度,对伴有和不伴有 VPI 和/或 PAI 的 NSCLC 进行 Kaplan-Meier 生存分析。计算对数秩检验统计量。
与实性结节相比,亚实性结节中 PAI 发生率明显低于 VPI(4.9%对 27.7%[p<0.0001]),相应的,亚实性结节的肺癌生存率明显高于实性结节(99.1%对 91.3%[p=0.0009])。多变量 Cox 回归发现,只有肿瘤直径(调整后的危险比[HR]为 1.07,95%置信区间[CI]为 1.01-1.14,p=0.02)和 PAI(调整后的 HR 为 3.15,95%CI 为 1.25-7.90,p=0.01)仍然显著,而 VPI 不显著(p=0.15)。当临床和计算机断层扫描结果与病理结果结合时,Cox 回归显示,在实性结节患者中,死于肺癌的风险增加 10 倍(HR 为 10.06,95%CI 为 1.35-75.30),在中度至重度肺气肿患者中增加两倍(HR 为 2.27,95%CI 为 1.01-5.11),以及肿瘤直径增加(HR 为 1.06,95%CI 为 1.01-1.13),而 PAI 不再显著(p=0.19)。
CT 结节密度是比 PAI 或 VPI 更重要的预后指标。我们建议,对于 VPI 最大肿瘤直径不超过 30mm 的 NSCLC 患者,除非有更大的、多中心的 NSCLC 研究进一步证实 T 分期的新分类,否则不应将其升级为 T2,且应分别对亚实性或实性结节患者进行分类。